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bjectives This study investigated the relationship between the index of microcirculatory resistance
IMR) with myocardial injury and microvascular obstruction (MVO) assessed by contrast-enhanced
ardiac magnetic resonance (ceCMR) imaging in a broad range of ST-segment elevation myocardial
nfarction (STEMI) patients undergoing emergency percutaneous coronary intervention (PCI).
ackground Contrast-enhanced cardiac magnetic resonance imaging is the gold standard for as-
essment of microvascular obstruction (MVO), left ventricular (LV) ejection fraction, and infarct vol-
mes in ST-segment elevation myocardial infarction (STEMI). However, ceCMR is not available
cutely. The index of microcirculatory resistance is a simple invasive measure of microvascular func-
ion available at the time of emergency PCI. We investigated the relationship between IMR with
yocardial injury and MVO assessed by ceCMR in STEMI patients undergoing emergency PCI.
ethods Fifty-seven patients with STEMI were included and 53 (93%) and 47 (82%) patients had
omplete ceCMR scans 2 days and 3 months following MI, respectively. Microvascular obstruction
as deﬁned as a dark core of hypoenhancement within the area of hyperenhanced infarct tissue
0 to 15 min following intravenous gadolinium (0.1 mmol/kg).
esults The median IMR (interquartile range [IQR]) was 35 (24 to 63) U. Twenty-seven patients
46%) had MVO. We found that IMR (median [IQR]) was higher in patients with MVO (38 [29 to 55]
) than in patients without MVO (27 [18 to 36] U); p  0.003). The index of microcirculatory resis-
ance was a negative multivariable predictor of LV ejection fraction, (p  0.001) and infarct volume
p  0.01) on the ceCMR scan 2 days after MI, and IMR was a multivariable predictor of LV ejection
raction (p  0.028) and infarct volume (p  0.048) at 3 months.
onclusions The index of microcirculatory resistance measured acutely was higher in patients with
VO on ceCMR, and IMR independently predicted LV function and infarct volume. This easily mea-
ured physiological parameter provides important prognostic information at the time of emergency
CI. (J Am Coll Cardiol Intv 2010;3:715–22) © 2010 by the American College of Cardiology
oundation
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716mergency percutaneous coronary intervention (PCI) is the
stablished treatment for ST-segment elevation myocardial
nfarction (STEMI). Despite achieving normal epicardial
rtery flow in the majority of patients, up to one-third of
atients do not achieve myocardial microvascular reperfu-
ion (1,2). Microvascular dysfunction in this setting is
ssociated with an adverse prognosis (3–5). However, there
s no established method for evaluating the coronary micro-
irculation in STEMI patients in the cardiac catheterization
aboratory.
The index of microcirculatory resistance (IMR) is a novel
ressure-/temperature-tipped guidewire-based quantitative
easure of coronary microvasculature function. The index of
icrocirculatory resistance has been validated in animal models
nd tested in stable patients (6–8), and in a recent study of
cute STEMI patients, IMR was a better predictor of left
entricular (LV) function 3 months after MI than current
tandard methods for evaluating the microcirculation (9).
Contrast-enhanced cardiac mag-
netic resonance imaging (ceCMR)
is the gold standard noninvasive
technique for assessment of the
coronary microcirculation (10).
Microvascular obstruction (MVO)
on ceCMR following STEMI
(Fig. 1) is associated with an adverse
prognosis (11,12). However, for
safety reasons, ceCMR is generally
not performed until 2 or more days
after hospital admission, limiting its
clinical utility in the initial post-MI
period.
In a broad range of STEMI
patients, we aimed to determine
whether IMR and other invasive
physiological markers of micro-
ascular dysfunction acquired immediately after stent de-
loyment in emergency PCI for STEMI might predict the
ature and severity of myocardial injury using ceCMR as
he gold standard comparison. Specifically, we first hypoth-
sized that an elevated IMR at the time of reperfusion
ould be associated with the nature of MI, as revealed by
he occurrence of MVO on ceCMR. Second, we hypothe-
ized that IMR would be independently predictive of the
everity of MI, as subsequently revealed by infarct size and
V function on ceCMR during long-term follow-up.
ethods
tudy design and population. The study population in-
luded patients with STEMI referred to our institution for
rimary PCI or after failed intravenous thrombolytic ther-
bbreviations
nd Acronyms
eCMR  contrast-enhanced
ardiac magnetic resonance
maging
MR  index of
icrocirculatory resistance
V  left ventricular
VO  microvascular
bstruction
CI  percutaneous
ntervention
TEMI  ST-segment
levation myocardial
nfarction
IMI  Thrombolysis In
yocardial Infarctionpy for rescue PCI, or who underwent cardiac catheteriza- pion within 24 h of successful thrombolytic therapy. Patients
ere prospectively enrolled when the following inclusion
riteria were present: 1) age 18 years with electrocardio-
raphic and symptomatic evidence of acute STEMI and in
hom emergency PCI was intended; and 2) written in-
ormed consent. Exclusion criteria were: 1) standard con-
raindications to CMR: pacemakers; cochlear implants;
ome types of prosthetic heart valves, surgical prostheses, or
ascular clips; metal intraocular foreign bodies; 2) contrain-
ications to gadolinium including estimated glomerular
ltration rate 30 ml/min/1.73 m2; sickle cell anemia;
emolytic anemia; 3) contraindications to adenosine; 4)
ardiogenic shock; 5) previous MI in the index territory; and
) pregnancy. The protocol was approved by the Institu-
ional Review Board and informed consent was obtained
rom each patient.
HYSIOLOGICAL ASSESSMENT. Percutaneous coronary in-
ervention was performed in line with current international
uidelines. Glycoprotein IIb/IIIa inhibitors and thrombec-
omy catheters were used at the discretion of the primary
perator. In the majority of cases, the coronary pressure-/
emperature-sensitive guidewire (Radi Medical Systems,
ppsala, Sweden) was used as the primary guidewire. The
uidewire was calibrated outside the body, equalized within
he guide catheter, with the pressure sensor positioned at
he ostium of the guide catheter. In all cases, the guidewire
icrosensor position was advanced into the distal third of
he culprit artery. Great care was taken to ensure the
osition of the microsensor was constant throughout the
Figure 1. Late Gadolinium Enhancement of an Anterior MI
Following Reperfusion
Late gadolinium enhancement of an anterior myocardial infarction 48 h
following reperfusion. A microvascular obstruction (MVO) can be seen (left)
as hypoenhancement within the hyperenhanced area. Axial views of ante-
rior myocardial infarction (MI) revealed by late gadolinium contrast-en-
hanced magnetic resonance imaging (MRI). In the left image, there is no
microvascular obstruction within the infarct zone, whereas in the right
image there is a microvascular obstruction, as indicated by the yellow
arrows. The central dark zone is due to the failure of the contrast agent to
penetrate within the infarct core.rocedure.
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717The IMR was calculated at the end of the procedure
sing the mean transit time (in seconds) of 3  3 ml bolus
f room-temperature saline injected into the coronary os-
ium during maximal hyperemia as previously described
13). Meticulous attention was paid to guide catheter
ngagement. Adenosine 140 g/kg/min was used to induce
aximal hyperemia via a large peripheral vein. The mean
ortic and distal coronary pressures were recorded during
aximal hyperemia.
We defined IMR as the distal coronary pressure multi-
lied by the mean transit time of the 3-ml saline bolus at
aximal hyperemia, measured simultaneously (mm Hg s,
r units). Subsequently, the stented segment was occluded
ith a short noncompliant balloon, and mean distal coro-
ary wedge pressure was recorded. The pressure-derived
ollateral flow index was calculated as the ratio of the mean
edge pressure to mean aortic pressure at hyperemia (14).
ECMR PROTOCOLS. The initial scan was performed 24 to
8 h after PCI. Scanning was performed using a Siemens
onata 1.5-T (Erlangen, Germany) scanner using a 6-channel
nterior chest coil and spinal coils within the gantry table.
efore scanning, electrocardiograph electrodes were posi-
ioned to achieve the best possible signal within the mag-
etic field of the scanner. Following the acquisition of
ocalizing images, we obtained long- and short-axis cine
mages using a retrospectively gated breath-hold true fast
maging with steady precession sequence. The short-axis
ine scans of 10-mm slices were used to determine LV mass,
olume, and function.
A bolus of contrast medium, gadolinium-diethylenetriamine
enta-acetic acid bismethylamide (Omniscan, Amersham
ealth, Oslo, Norway) was injected at a dose of 0.1
mol/kg. Following the first pass, early gadolinium-
nhancement images were obtained using a segmented true
ast imaging with steady precession sequence across the
V short axis at 1-min intervals from 2 up to 5 min
ollowing the bolus. We then collected a series of images
n both the long- and short-axis planes looking for
elayed gadolinium enhancement using a turbo fast low
ngle shot sequence allowing assessment for the presence
f MVO. We defined MVO as an area of hypoenhance-
ent within the gadolinium hyperenhanced area of
nfarcted tissue present early after contrast injection and
ersistent when reimaged 15 min following contrast
njection (Fig. 1) (12).
ECMR ANALYSIS. Left ventricular mass, volume, and func-
ion analyses were performed by a cardiologist experienced
n ceCMR who was blinded to all clinical and pressure wire
ata. Results were obtained using Argus Dynamic Signal
oftware (Siemens, Erlangen, Germany) by drawing endo-
ardial and epicardial contours using the short-axis cine
mages at both end diastole and end systole. Images with iate gadolinium enhancement were analyzed for the pres-
nce of MVO as previously defined by 2 experienced
linded observers, and a third experienced observer adjudi-
ated when disagreement occurred. Infarct territories and
VO were manually delineated (11,12). Additionally, 2
ther cardiologists experienced in ceCMR (S.W., C.B.) also
eviewed the MVO analyses. For categorical analyses,
VO was defined as present or absent.
IOCHEMICAL ASSESSMENT. Troponin I concentration in
ubital venous blood was measured 12 to 24 h after MI
sing an automated analyzer (Advia Centaur, Bayer Diag-
ostics, Indianapolis, Indiana). The limit of detection was
0.2 g/l.
TATISTICAL ANALYSIS. Invasive markers of microvascular
unction (coronary wedge pressure, pressure-derived collat-
ral flow index, and IMR) were non-normally distributed
nd are summarized with the median value and interquartile
ange (IQR). The Mann-Whitney U test was used to
ompare these data between patients with or without MVO
s revealed by ceCMR. An elevated IMR was defined as
reater than the median value. Log-transformed invasive
arkers of microvascular function and other clinical features
such as those presented in Tables 3 and 4) were compared
ith ceCMR outcomes using univariate regression analysis.
he univariable predictors with a p value of less than 0.1
ere entered into a multivariate model. Because our focus
as to evaluate the predictive value of IMR compared with
ther clinical characteristics that were available at the time
f primary PCI, only variables that were clinically available
t that time, such as time-to-reperfusion but not troponin
oncentration, were included in the multivariable models. A
value 0.05 was considered statistically significant. Sta-
istical analyses were performed on MINITAB 14 software
Minitab, Inc., State College, Pennsylvania).
esults
atient characteristics and procedure outcomes. Fifty-seven
atients were prospectively enrolled and their clinical char-
cteristics are presented in Table 1. Physiological measure-
ents were acquired in all patients. In 1 patient, the
oronary wedge pressure was not obtained due to a poor
uality signal. As this patient underwent balloon angioplasty
ithout stenting, it was not clinically appropriate to perform
urther balloon inflations necessary for wedge pressure
easurement.
The culprit artery was the right coronary artery in 24
ases, the left anterior descending artery in 28 cases, the
ircumflex coronary artery in 4 cases, and the diagonal artery
n 1 patient. Emergency PCI was for primary intervention
n 26 cases, rescue in 16 cases, and prognostic (defined as
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718CI within 24 h of successful thrombolytic therapy) in 15
ases. The median (IQR) time from onset of pain to
eperfusion for patients undergoing primary or rescue PCI
as 4.3 h (2.2 to 7.0 h). The IMR, pressure-derived
ollateral flow index, and distal coronary wedge pressure
ere not related to pain-to-reperfusion time.
elationships between acute invasive measures of infarct
everity and subsequent ceCMR ﬁndings. The median IQR
or time from PCI to the ceCMR scan was 29 h (24 to 44)
nd the majority of patients (90%) underwent ceCMR
ithin 48 h after PCI. In 2 patients, the magnetic resonance
maging scan was not well tolerated and gadolinium was not
dministered.
The coronary microcirculatory data are shown in Table 1.
he median (IQR) IMR was 35 (24 to 63) U with a range
f 7 to 154 U. The ceCMR findings 2 days and 3 months
fter MI are shown in Table 2.
The median IMR (IQR) in patients with MVO was
igher (38 [29 to 55] U) than in patients without MVO (27
18 to 36] U; p  0.003) (Fig. 2). The pressure-derived
ollateral flow index and distal coronary wedge pressure
ere similar in both groups. Coronary microcirculatory
haracteristics were not related to MVO volume.
elationship between acute invasive measures of infarct severity
nd a biochemical measure of myocardial injury. We found
Table 1. Characteristics of 57 STEMI Patients
Mean age, yrs 58 (32–83)
Male sex, % 88
Current smoker, % 50
History of diabetes, % 6
Treated hypertension, % 27
History of hypercholesterolemia, % 27
TIMI ﬂow grade 3 after PCI, % 94
Mean transit time (hyperemia), s 0.45 (0.35–0.68)
Distal coronary wedge pressure, mm Hg* 23 (17–30)
Pressure-derived collateral ﬂow index* 0.28 (0.2–0.32)
Index of microcirculatory resistance 34.6 (22.8–51.1)
Fractional ﬂow reserve after PCI 0.90 (0.85–0.97)
Adjunctive therapy during PCI, %
Aspirin (300 mg) 100
Clopidogrel loading prior to PCI (600 mg) 100
Thrombectomy 46
Glycoprotein IIb/IIIa inhibitor therapy† 75
Medications at discharge, %
ACE inhibitor 94
Beta-blocker 87
Statin 100
Continuous data for coronary microvascular function are expressed as median (interquartile
range). *Available in 56 patients. †Glycoprotein IIb/IIIa inhibitor therapy was initiated in the
cardiac catheter laboratory at the beginning or during PCI.
ACE  angiotensin-converting enzyme; PCI  percutaneous coronary intervention; STEMI 
ST-segment elevation myocardial infarction; TIMI Thrombolysis In Myocardial Infarction.hat IMR correlated with peak troponin I (r  0.52, p .01) (Fig. 3) but not with either the pressure-derived
ollateral flow index or distal coronary wedge pressure.
nivariable and multivariable regression models of IMR and
eCMR outcomes. In univariable analyses, an elevated IMR
i.e., IMR greater than median value of 35 units) was a
egative predictor of LV ejection fraction and a positive
redictor of LV end-systolic volume index (p  0.035). In
ultivariable analyses, an elevated IMR was an independent
redictor of LV ejection fraction 2 days and 3 months after
I (Table 3). An elevated IMR was a multivariable
redictor of infarct size 2 days and 3 months after MI
Table 4).
omparison of IMR in patient subgroups. The median IMR
IQR) was 40 (30 to 55) U in those who underwent rescue
CI, 36 (21 to 60) U in those who had primary PCI and 24
17 to 35) U in those in whom PCI was performed within
4 h of successful reperfusion therapy on prognostic
rounds (rescue PCI vs. prognostic PCI, p 0.009; primary
CI vs. prognostic PCI, p  0.04).
Table 2. Contrast-Enhanced CMR Findings in 57 STEMI Patients
ceCMR Variables
2 Days
After MI
3 Months
After MI
Left ventricular ejection fraction, % 55.2 (11.9) 61.9 (10.8)
Left ventricular end-diastolic volume index, ml/m2 68.2 (13.6) 74.3 (17.8)
Left ventricular end-systolic volume index, ml/m2 30.5 (10.8) 28.9 (12.4)
Left ventricular infarct volume, ml 23.1 (22.6) 12.1 (11.2)
Microvascular obstruction, n (%) 27 (51) —
Continuous data are expressed as mean (SD). Data for MVO were available in 53 (93%) patients.
ceCMR contrast-enhanced cardiac magnetic resonance imaging; MImyocardial infarction;
MVOmicrovascular obstruction; other abbreviations as in Table 1.
Figure 2. IMR in Patients With and Without MVO
The median (interquartile range) index of microcirculatory resistance
(median [interquartile range]) was higher in patients with microvascular
obstruction (38 [29 to 55] U) than in patients without microvascular
obstruction (27 [18 to 36] U); p  0.003). The box limits represent the
interquartile range. The horizontal line within the box represents the
median value. Abbreviation as in Figure 1.
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719elationships between IMR and initial TIMI ﬂow grade. We
ound that IMR varied in relation to initial TIMI (Throm-
olysis In Myocardial Infarction) flow grade and was higher
n patients with no or minimal antegrade coronary flow
TIMI 0/1) than in patients with normal coronary flow
Figure 3. IMR Correlates With Peak Troponin I Concentration
The index of microcirculatory resistance correlates moderately well with
peak troponin I concentration (r  0.52; p  0.01). The scatter plot shows
peak troponin I concentration (g/l) after myocardial infarction and the
index of microcirculatory resistance obtained at the end of the primary per-
cutaneous coronary intervention. Abbreviation as in Figure 2.
Table 3. Results of Multivariable Regression Analyses for LVEF Measured
by ceCMR Performed 2 Days and 3 Months After MI
Univariate R2
(%)
Univariate
p Value
Multivariate
p Value*
Predictors of LVEF at day 2
Cigarette smoking 5.4 0.08 0.37
Diabetes 12.1 0.008 0.025
IMR 29.1 0.001 0.001
Time to reperfusion 9.5 0.02 0.096
ST-segment resolution 70% 7.7 0.037 0.21
Predictors of LVEF at 3 months
Hypercholesterolemia 9.4 0.01 0.016
Glycoprotein IIb/IIIa inhibitor 10.8 0.02 0.031
IMR 14.5 0.02 0.028
Time to reperfusion 9.1 0.035 0.446
ST-segment resolution 70% 12.3 0.013 0.175
Culprit artery 16.8 0.003 0.039
The variables entered into univariable models for LVEF measured by ceCMR at 2 days and 3
months follow-up, respectively, were age, male sex, cigarette smoking, hypercholesterolemia,
hypertension, diabetes, glycoprotein IIb/IIIa inhibitor therapy, aspiration thrombectomy, IMR,
fractional coronary collateral supply, coronarywedgepressure, culprit artery, time to reperfusion,
ST-segment resolution 70%, and culprit artery. The strongest univariate predictors with a p
value less the 0.1 were entered into a multivariate model to determine independent predictors.
*The rise in R2 value for each multivariate model including IMR as compared to all other
variables was 37.1% to 50.8% at 2 days and 54.5% to 58% at 3 months.
IMR  index of microcirculatory resistance; LVEF  left ventricular ejection fraction; otherabbreviations as in Table 2.TIMI 3) at pre-PCI angiography (p  0.05) (Table 5).
owever, IMR was similar in patients treated with or
ithout aspiration thrombectomy or glycoprotein IIb/IIIa
nhibitor therapy.
iscussion
icrocirculatory injury is a determinant of LV function
3,15) and prognosis following acute MI (4,12). Whereas
mergency PCI represents 1 of the first opportunities to
valuate and treat an acute MI patient, the optimal method
or evaluating the microcirculation in this setting is uncer-
ain (16).
The key findings in our study are as follows. First, in a
road range of STEMI patients undergoing emergency
CI, an invasive measure of microvascular function, the
Table 4. Results of Multivariable Regression Analyses for
Myocardial Infarct Volume Measured by ceCMR Performed
2 Days and 3 Months After MI
Univariate
R2 (%)
Univariate
p Value
Multivariate
p Value*
Predictors of infarct volume at day 2
Glycoprotein IIb/IIIa inhibitor 5.3 0.09 0.29
IMR 18.6 0.001 0.01
Time to reperfusion 11.1 0.016 0.32
ST-segment resolution 70% 14.7 0.005 0.06
Culprit artery 14.2 0.006 0.03
Predictors of infarct volume at 3 months
Hypercholesterolemia 9.1 0.04 0.112
IMR 15.6 0.006 0.048
ST-segment resolution 70% 9.9 0.031 0.384
Time to reperfusion 6.0 0.097 0.545
Culprit artery 21.3 0.001 0.021
The units of myocardial infarct volume are milliliters. The following variables were entered into
themultivariatemodels formyocardial infarct volumesmeasured by ceCMR 2 days and 3months
after MI: age, male sex, cigarette smoking, hypercholesterolemia, hypertension, diabetes, glyco-
protein IIb/IIIa inhibitor therapy, aspiration thrombectomy, IMR, fractional coronary collateral
supply, coronary wedge pressure, time to reperfusion, ST-segment resolution70%, and culprit
artery. The strongest univariate predictors with a p value less the 0.1 were entered into a multi-
variate model to determine independent predictors. *The rise in R2 value for each multivariate
model including IMRas compared to all other variableswas 51.3% to53.9%at 2days and40.7%
to 45.1% at 3 months.
Abbreviations as in Tables 2 and 3.
Table 5. The Relationships Between IMR and pre-PCI TIMI Flow Grade
TIMI Flow Grade n Median IMR (IQR)
0 21 37 (26.9–53.1)
1 17 34.8 (24.9–63.6)
2 10 32.1 (15–50.9)
3 9 23.1 (17.3–31.6)IQR interquartile range; other abbreviations as in Tables 1 and 3.
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720MR, was linked with the pathological nature of MI,
ecause IMR was higher in patients with MVO than in
hose without MVO, as revealed by ceCMR. Second, IMR
ndependently predicted the severity of MI as revealed by
nfarct volume and LV function 2 days and 3 months after
I. Third, IMR, but not coronary wedge pressure or
ractional collateral supply, independently predicted infarct
ize.
To date, IMR has been subject to pre-clinical and clinical
alidation, and these studies have demonstrated that IMR
easurement is largely independent of variations in hemo-
ynamic state (6–8). A seminal study by Fearon et al. (9)
onfirmed the IMR to be superior to other commonly used
linical markers of microvascular dysfunction for predicting
V function assessed by echocardiography.
Our study is the first to compare invasively acquired
easurements of microvascular injury using the coronary
ressure wire with LV function and MVO assessed by
aired ceCMR studies obtained acutely and after longer-
erm follow-up. Contrast-enhanced CMR is recognized as
he current noninvasive gold standard for assessment of
oronary microvascular damage and LV function and di-
ensions (10). A recent study by Hirsch et al. (17) quan-
ified coronary blood flow characteristics using an intra-
oronary Doppler wire and related these findings to micro-
ascular injury assessed by ceCMR. Twenty-seven anterior
Figure 4. Thermodilution Curves at Rest and in Hyperemia
Thermodilution curves under resting conditions (blue lines) and during hyper
modilution curves at baseline and hyperemia (seconds) as seen in the cathete
RADI analyzer (Radi Medical Systems, Uppsala, Sweden).TEMI patients underwent repeat cardiac catheterization 4
o 8 days after primary PCI with ceCMR performed the
receding day. This study demonstrated that the extent of
VO was a multivariable predictor of abnormal coronary
ow velocity characteristics, providing further functional
vidence of the validity of ceCMR as a noninvasive tool to
ssess microcirculatory function. These observations com-
lement those in the current study.
Here, IMR predicted LV injury as assessed by ceCMR
nd correlated significantly with troponin I, which is a
iochemical marker of infarct size. Our study is also the first
irect comparison of IMR with other physiological mea-
ures of microvascular dysfunction (18). The other postu-
ated coronary pressure/temperature wire-derived markers
f microvascular injury (pressure-derived collateral flow
ndex and distal coronary wedge pressure) did not correlate
ith the severity or nature of MI as assessed by ceCMR.
Our findings complement those of the other previously
ublished studies in a number of important ways. Our study
ad a larger sample size and included patients with a
roader range of acute MI types (e.g., nonanterior STEMI).
he time to presentation from the onset of symptoms for
atients in our study was less restricted than in previous
tudies that excluded patients with symptoms 12 h
9,17,19). Therefore, our results extend the potential clinical
elevance of IMR measurement to a larger group of patients
nduced by intravenous adenosine infusion. Graphical representation of ther-
atory at the time of percutaneous coronary intervention displayed on theemia i
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721ith MI. The median IMR in our study population was 35
nits, which is similar to that reported by Fearon et al. (9)
median IMR: 32 U). Our findings are consistent with and
xtend the results of these earlier studies and support the
otion that standardized measurement of IMR may be valid
n clinical practice. Consequently, our results support the
otion that invasive measures of microvascular function may
e useful clinical tools to predict the initial severity of
yocardial injury.
Only a minority of patients had a history of hypertension
r diabetes and patients with previous MI in the culprit
rtery territory were not included. Therefore, the microvas-
ular dysfunction observed in our patients was most likely
nfluenced by the effects of acute coronary thrombosis and
eperfusion, rather than the effects of chronic microvascular
isease related to pre-existing cardiac disease.
tudy limitations. Microvascular obstruction is a dynamic
henomenon following coronary reperfusion, and MVO
hat may be apparent on ceCMR initially may resolve by
8 h. In fact, MVO that is detectable 2 days after MI is
ore correctly termed persistent MVO. The dynamic na-
ure of MVO may in part explain why elevated IMR values
35 may occur in some patients with no visible MVR on
eCMR scanning 2 days later (20). Serial ceCMR up to
8 h after MI would be required to answer this question.
he time point used to assess MVO by ceCMR is consis-
ent with other studies of this subject, and MVO measured
t this time point is an adverse prognostic marker (4).
The study is limited by its small sample size; however,
MR remains a significant predictor of myocardial damage.
larger sample size may have resulted in other predictors
ecoming significant. Larger studies will be needed to
etermine whether IMR can predict clinical outcomes.
onclusions
he index of microcirculatory resistance is a simple wire-
ased technique that can provide a quantitative assessment
f microvascular function at the time of emergency PCI.
e have shown that an elevated IMR is linked to MVO as
evealed by ceCMR. MVO independently predicts long-
erm prognosis following MI. Accordingly, we suggest
easurement of IMR represents a new approach to risk
ssessment at the very earliest stage of acute MI manage-
ent, and, therefore, potentially enables a triage of higher
isk patients to more intensive therapy (Fig. 4).
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